GST Reforms to Boost Healthcare Affordability in India

Boehringer Ingelheim India has praised the GST Council's recent decision to lower tax rates on medicines and life-saving drugs, a move expected to enhance public health access and stimulate industry growth.

The reforms, which also include GST exemptions on individual health insurance, aim to make it more affordable for the general public, potentially driving wider insurance coverage across the nation. This initiative is seen as a critical step towards building an inclusive healthcare system.

Boehringer Ingelheim India is realigning its pricing to reflect the new GST rates and is working with healthcare stakeholders to ensure effective implementation. The company views these changes as foundations for a sustainable and innovative healthcare ecosystem.

(With inputs from agencies.)